MARIBELLE BLACKMON: Open Payments
NPI 1972905305 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 12 payments from 4 companies in 2025. Trend: 2023 $98 · 2024 $158 · 2025 $237
Food & beverage: $192Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $89 |
| ABBVIE INC. | 4 | $73 |
| Lilly USA, LLC | 2 | $62 |
| Amgen Inc. | 1 | $14 |
Products named: Wegovy, UBRELVY, QULIPTA, ZEPBOUND, REPATHA.
Industry payments across VA — which companies pay providers there.
